ADAM28 anticorps (AA 199-440)

N° du produit ABIN7150051

Cet anticorps anti-ADAM28 est un anticorps Lapin Polyclonal détectant ADAM28 dans WB, IHC et ELISA. Adapté pour Humain.

Aperçu rapide pour ADAM28 anticorps (AA 199-440) (ABIN7150051)

Antigène: ADAM28 (ADAM Metallopeptidase Domain 28 (ADAM28))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ADAM28 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Détail du produit anti-ADAM28 anticorps

Épitope: AA 199-440

Fonction: ADAM28 Antibody

Purification: Antigen Affinity Purified

Immunogène: Recombinant Human Disintegrin and metalloproteinase domain-containing protein 28 protein (199-440AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur ADAM28

Antigène: ADAM28 (ADAM Metallopeptidase Domain 28 (ADAM28))

Autre désignation: ADAM28

Sujet:

Background: May play a role in the adhesive and proteolytic events that occur during lymphocyte emigration or may function in ectodomain shedding of lymphocyte surface target proteins, such as FASL and CD40L. May be involved in sperm maturation.

Aliases: ADAM28 antibody, ADAM23 antibody, MDCLDisintegrin and metalloproteinase domain-containing protein 28 antibody, ADAM 28 antibody, EC 3.4.24.- antibody, Epididymal metalloproteinase-like antibody, disintegrin-like antibody, and cysteine-rich protein II antibody, eMDC II antibody, Metalloproteinase-like antibody, disintegrin-like antibody, and cysteine-rich protein L antibody, MDC-L antibody

UniProt: Q9UKQ2